Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
A majority of Americans support higher pay for auto workers who are on strike against Detroit's Big Three carmakers, although approval of the workers' other demands is more mixed, according to a poll from The Associated Press-NORC Center for Public Affairs Research.
